» Articles » PMID: 37561052

Revisiting the Personal Protective Equipment Components of Transmission-based Precautions for the Prevention of COVID-19 and Other Respiratory Virus Infections in Healthcare

Abstract

The COVID-19 pandemic highlighted some potential limitations of transmission-based precautions. The distinction between transmission through large droplets vs aerosols, which have been fundamental concepts guiding infection control measures, has been questioned, leading to considerable variation in expert recommendations on transmission-based precautions for COVID-19. Furthermore, the application of elements of contact precautions, such as the use of gloves and gowns, is based on low-quality and inconclusive evidence and may have unintended consequences, such as increased incidence of healthcare-associated infections and spread of multidrug-resistant organisms. These observations indicate a need for high-quality studies to address the knowledge gaps and a need to revisit the theoretical background regarding various modes of transmission and the definitions of terms related to transmission. Further, we should examine the implications these definitions have on the following components of transmission-based precautions: (i) respiratory protection, (ii) use of gloves and gowns for the prevention of respiratory virus infections, (iii) aerosol-generating procedures and (iv) universal masking in healthcare settings as a control measure especially during seasonal epidemics. Such a review would ensure that transmission-based precautions are consistent and rationally based on available evidence, which would facilitate decision-making, guidance development and training, as well as their application in practice.

Citing Articles

The Impact of Infection Control Policies on Hospital Acquired Infections by MDROs from 2016 to 2023.

Wang Y, Zhang Y, Wang Q, Li W, Shi D, Xu Y Infect Drug Resist. 2024; 17:4213-4221.

PMID: 39359495 PMC: 11446211. DOI: 10.2147/IDR.S481412.


Doff Thy Gown-Shedding Contact Precautions for COVID-19.

Rabin A, Marr L, Blumberg H Clin Infect Dis. 2024; 79(3):585-587.

PMID: 38747695 PMC: 11426274. DOI: 10.1093/cid/ciae276.

References
1.
van der Valk J, In t Veen J . SARS-Cov-2: The Relevance and Prevention of Aerosol Transmission. J Occup Environ Med. 2021; 63(6):e395-e401. PMC: 8168703. DOI: 10.1097/JOM.0000000000002193. View

2.
Tellier R . Aerosol transmission of influenza A virus: a review of new studies. J R Soc Interface. 2009; 6 Suppl 6:S783-90. PMC: 2843947. DOI: 10.1098/rsif.2009.0302.focus. View

3.
Kratzel A, Todt D, Vkovski P, Steiner S, Gultom M, Thao T . Inactivation of Severe Acute Respiratory Syndrome Coronavirus 2 by WHO-Recommended Hand Rub Formulations and Alcohols. Emerg Infect Dis. 2020; 26(7):1592-1595. PMC: 7323537. DOI: 10.3201/eid2607.200915. View

4.
Loveday H, Wilson J, Pratt R, Golsorkhi M, Tingle A, Bak A . epic3: national evidence-based guidelines for preventing healthcare-associated infections in NHS hospitals in England. J Hosp Infect. 2013; 86 Suppl 1:S1-70. PMC: 7114876. DOI: 10.1016/S0195-6701(13)60012-2. View

5.
Killingley B, Mann A, Kalinova M, Boyers A, Goonawardane N, Zhou J . Safety, tolerability and viral kinetics during SARS-CoV-2 human challenge in young adults. Nat Med. 2022; 28(5):1031-1041. DOI: 10.1038/s41591-022-01780-9. View